Drawing for ENTERIX

USPTO serial 98218342

ENTERIX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RINGLE, JAMES W
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENTERIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark D. Swanson

Mark D. Swanson PAULEY ERICKSON & SWANSON10 EXECUTIVE COURTSUITE 3SOUTH BARRINGTON, IL 60010

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations for the reduction of methanogenesis in ruminants, for use in promoting well-being of ruminants in the nature of complementary and medicated animal feed, dietetic food and substances adapted for veterinary use, namely, dietary supplements for ruminants and medicated ruminant feed; dietary supplements for ruminants; preparations for gastrointestinal modification in ruminants; veterinary preparations for gastrointestinal modification in ruminants; veterinary and medical pharmaceutical preparations for the treatment of bacterial overgrowth in ruminants; bacteriostats for dental and veterinary use for ruminants; veterinary preparations for treatment, control, and modification of intestinal bacteria in ruminants; bacteriological preparations for veterinary purposes for ruminants; anti-bacteriological and antimicrobial preparations for veterinary purposes for ruminants; food supplements for veterinary purposes for ruminants; pharmaceutical preparations for the treatment and modification of gastro-intestinal conditions in ruminants; natural remedy preparations for the treatment and modification of gastro-intestinal conditions in ruminants; biological preparations for the treatment and modification of gastro-intestinal conditions in ruminants; gastro-intestinal treatment preparations for ruminants; nutraceuticals for the treatment and modification of gastrointestinal flora in ruminants; chemical preparations for ruminant veterinary purposes in the nature of powder and liquid form containing combinations of plant extracts, Allicin, garlic extracts, compounds extracted and derived from garlic and polyphenols; chemical reagents for veterinary purposes; chemical preparations for veterinary purposes containing combinations of plant extracts, Allicin, garlic extracts, compounds extracted and derived from garlic and polyphenols for , namely, for the reduction of methanogenesis in ruminants, and for use in promoting well-being of ruminants; chemico-pharmaceutical preparations for the reduction of methanogenesis in ruminants, the reduction of greenhouse gas emissions produced by ruminants, promoting the general well-being of ruminants in the nature of complementary and medicated animal feed; medicinal herbs for veterinary use in ruminants; medicinal oils for veterinary use in ruminants; parasiticides for veterinary use in ruminants; plant extracts for nutraceutical use, namely plant extracts for promoting immune health and heart health in ruminants; plant extracts for dietetic use, namely, plant extracts for use for promoting immune health and heart health in ruminants; plant extracts for nutritional purposes for promoting immune health and heart health in ruminantsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 3, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 30, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 26, 2024DOCKASSIGNED TO EXAMINER—
Dec 20, 2023TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Dec 20, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance